Ferlins Show Tissue‐Specific Expression and Segregate as Plasma Membrane/Late Endosomal or Trans‐Golgi/Recycling Ferlins GMI Redpath, RA Sophocleous, L Turnbull, CB Whitchurch, ST Cooper Traffic 17 (3), 245-266, 2016 | 64 | 2016 |
The P2X7 receptor antagonist JNJ-47965567 administered thrice weekly from disease onset does not alter progression of amyotrophic lateral sclerosis in SOD1G93A mice D Ly, A Dongol, P Cuthbertson, TV Guy, NJ Geraghty, RA Sophocleous, ... Purinergic signalling 16 (1), 109-122, 2020 | 28 | 2020 |
P2Y2 and P2X4 Receptors Mediate Ca2+ Mobilization in DH82 Canine Macrophage Cells RA Sophocleous, NA Miles, L Ooi, R Sluyter International Journal of Molecular Sciences 21 (22), 8572, 2020 | 22 | 2020 |
The P2X4 receptor: cellular and molecular characteristics of a promising neuroinflammatory target RA Sophocleous, L Ooi, R Sluyter International Journal of Molecular Sciences 23 (10), 5739, 2022 | 20 | 2022 |
Propensity of red blood cells to undergo P2X7 receptor–mediated phosphatidylserine exposure does not alter during in vivo or ex vivo aging RA Sophocleous, PRF Mullany, KM Winter, DC Marks, R Sluyter Transfusion 55 (8), 1946-1954, 2015 | 19 | 2015 |
Autocrine regulation of wound healing by ATP release and P2Y2 receptor activation TBD McEwan, RA Sophocleous, P Cuthbertson, KJ Mansfield, ... Life Sciences 283, 119850, 2021 | 16 | 2021 |
Pharmacological and genetic characterisation of the canine P2X4 receptor RA Sophocleous, T Berg, RK Finol‐Urdaneta, V Sluyter, S Keshiya, L Bell, ... British Journal of Pharmacology 177 (12), 2812-2829, 2020 | 14 | 2020 |
A new class of quadruplex DNA-binding nickel Schiff base complexes SQT Pham, N Assadawi, J Wells, RA Sophocleous, KJ Davis, H Yu, ... Dalton Transactions 49 (15), 4843-4860, 2020 | 14 | 2020 |
Loss of calpains-1 and-2 prevents repair of plasma membrane scrape injuries, but not small pores, and induces a severe muscular dystrophy AK Piper, RA Sophocleous, SE Ross, FJ Evesson, O Saleh, A Bournazos, ... American Journal of Physiology-Cell Physiology 318 (6), C1226-C1237, 2020 | 13 | 2020 |
Limited proteolysis as a tool to probe the tertiary conformation of dysferlin and structural consequences of patient missense variant L344P N Woolger, A Bournazos, RA Sophocleous, FJ Evesson, A Lek, B Driemer, ... Journal of Biological Chemistry 292 (45), 18577-18591, 2017 | 9 | 2017 |
P2X7 receptor activation causes phosphatidylserine exposure in canine erythrocytes M Faulks, TA Kuit, R Sophocleous, BL Curtis, SJ Curtis, LM Jurak, ... | 8 | 2016 |
Animal models for the investigation of P2X7 receptors R Sluyter, S Adriouch, SJ Fuller, A Nicke, RA Sophocleous, D Watson International Journal of Molecular Sciences 24 (9), 8225, 2023 | 7 | 2023 |
P2X receptors: Insights from the study of the domestic dog R Sluyter, RA Sophocleous, L Stokes Neuropharmacology 224, 109358, 2023 | 5 | 2023 |
6-furopyridine hexamethylene amiloride is a non-selective P2X7 receptor antagonist P Cuthbertson, A Elhage, D Al-Rifai, RA Sophocleous, RJ Turner, ... Biomolecules 12 (9), 1309, 2022 | 5 | 2022 |
Association of a P2RX7 gene missense variant with brachycephalic dog breeds RA Sophocleous, V Sluyter, BL Curtis, SJ Curtis, LM Jurak, M Faulks, ... Animal Genetics 51 (1), 127-131, 2020 | 4 | 2020 |
From dolphins to dogs: new opportunities to understand the role of P2X4 receptors in spinal cord injury and neuropathic pain RA Sophocleous, R Sluyter Neural Regeneration Research, 2022 | 2 | 2022 |
Second meeting of the Australian and New Zealand Purine Club C Gubert, RA Sophocleous, R Sluyter, SM Vlajkovic, JME Cederholm Purinergic Signalling 18 (4), 385-386, 2022 | 1 | 2022 |
Methods for studying P2X4 receptor ion channels in immune cells R Sluyter, TBD McEwan, RA Sophocleous, L Stokes Journal of Immunological Methods, 113626, 2024 | | 2024 |
Third meeting of the Australian and New Zealand Purine Club RA Sophocleous, R Sluyter, C Gubert, SM Vlajkovic, JME Cederholm Purinergic Signalling 19 (4), 595-598, 2023 | | 2023 |
P2X4 受体: 有前途的神经炎症靶点的细胞和分子特征 RA Sophocleous, R Sluyter 中国神经再生研究 (英文版) 18 (7), 1497, 2023 | | 2023 |